ALX Oncology Holdings Inc.
ALXO
$0.5662
$0.01622.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -29.16M | -30.71M | -39.40M | -35.58M | -45.47M |
| Total Depreciation and Amortization | 214.00K | -222.00K | 666.00K | 214.00K | 207.00K |
| Total Amortization of Deferred Charges | 69.00K | 66.00K | 66.00K | 64.00K | 64.00K |
| Total Other Non-Cash Items | 5.59M | 6.81M | 5.89M | 5.94M | 5.19M |
| Change in Net Operating Assets | -8.76M | -1.32M | 6.21M | -8.56M | 331.00K |
| Cash from Operations | -32.05M | -25.38M | -26.57M | -37.92M | -39.68M |
| Capital Expenditure | -60.00K | -149.00K | -90.00K | -148.00K | -148.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.24M | 25.84M | 997.00K | 26.62M | -16.52M |
| Cash from Investing | 33.18M | 25.69M | 907.00K | 26.47M | -16.67M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -76.00K | -358.00K | -218.00K | -175.00K | -63.00K |
| Issuance of Common Stock | 45.00K | -- | 31.29M | 237.00K | 63.63M |
| Repurchase of Common Stock | -- | -29.59M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 359.00K | 30.20M | -3.92M | 3.02M | -4.40M |
| Cash from Financing | 328.00K | 251.00K | 27.15M | 3.09M | 59.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.47M | 568.00K | 1.49M | -8.37M | 2.82M |